Successful outcome of neoadjuvant PD-1 blockade, VEGFR-2 inhibitor plus chemotherapy for potentially unresectable esophagogastric junctional squamous cell carcinoma: a case report

BACKGROUND: Esophagogastric junctional squamous cell carcinoma (EJSCC) is quite rare among all gastric carcinoma, its potential resectable rate is low due to the late diagnosis. Recently, programmed death-1 (PD-1) blockade combined with anti-angiogenesis have gained accumulated clinical experiences...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kai-Bo, Wu, Zhi-Wei, Huang, Yi, Kang, Mu-Xing, Lin, Le-Le, Jiang, Shan-Shan, Zhang, Hui, Huang, Ya-Jing, Chen, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552059/
https://www.ncbi.nlm.nih.gov/pubmed/36237240
http://dx.doi.org/10.21037/tcr-22-789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552059/
https://www.ncbi.nlm.nih.gov/pubmed/36237240
http://dx.doi.org/10.21037/tcr-22-789

Ejemplares similares